ATHN 9 VWD (Shire/Takeda) -- 12/2017-12/2024
1.5 million dollars awarded 12/2017
Characterizing patients with severe VWD in the United Stated enrolled in the ATHNdataset.
Co-PI's: Sidonio and Weyand
MOTIVATE Study -- 12/2018-12/2028
2 million dollars awarded 12/2018
Prospective (and partly retrospective), observational, international study to capture different approaches to ITI (Emicizumab only, Bypassing agent only and the Atlanta Protocol)
Co-I's: Sidonio and Escuriola
Hemophilia of Georgia VWD Grant -- 06/2023-06/2025
1 million dollars awarded 06/2023
VWD grant focusing on novel assay development, diagnosis in adolescent girls and characterization of low VWF
Co-I's: Sidonio, Brown, Zimowski, and Li
Investigator Initiated Grant (LFB)
$500,000 to be awarded April 2024
Investigate the hemostatic efficacy of Eptacog Beta in Glamnzmann Thrombasthenia
Co-I's: Sidonio and Zimowski
Von Willebrand Prophylaxis Network (Takeda and Octapharma)
Total 1 million dollars to be awarded June 2024
Investigate the population pharmacokinetics of VWF concentrate in persons with VWD
Co-I's: Sidonio and O'Donnell